|
|
Volumn 198, Issue 2, 2013, Pages 72-73
|
|
Familial hypercholesterolaemia in australia: New insights and developments: A model of care is in place but the challenge of early detection remains
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
APOLIPOPROTEIN B100;
CHOLESTEROL;
EZETIMIBE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
KEXIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MONOCLONAL ANTIBODY;
SUBTILISIN;
ACCESS TO INFORMATION;
APHERESIS;
AUSTRALIA AND NEW ZEALAND;
BLOOD ANALYSIS;
CEREBROVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
CONSENSUS DEVELOPMENT;
CORNEA CURVATURE;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
EARLY DIAGNOSIS;
EDITORIAL;
FAMILIAL HYPERCHOLESTEROLEMIA;
FAMILY HISTORY;
GENE MUTATION;
GENETIC ANALYSIS;
GOOD CLINICAL PRACTICE;
HEALTH PROGRAM;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
INTERNET;
ISCHEMIC HEART DISEASE;
LIFE EXPECTANCY;
MEDICAL HISTORY;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
PATHOGENESIS;
PATIENT COMPLIANCE;
PERIPHERAL VASCULAR DISEASE;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
SMOKING;
XANTHOMA;
ADOLESCENT;
ADULT;
ANTICHOLESTEREMIC AGENTS;
AUSTRALIA;
CHILD;
EARLY DIAGNOSIS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPOPROTEINEMIA TYPE II;
|
|
EID: 84874637586
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/mja12.11467 Document Type: Editorial |
|
Times cited : (3)
|
|
References (7)
|
